Back

“Hold the drug, strength tomorrow”: The prognostic effect of therapy adherence after a hospitalisation for heart failure with reduced ejection fraction

30 August 2026 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: Diagnostic and prognostic biomarkers in heart failure (2) Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Pal Peter Schaffer

Gottsegen National Cardiovascular Center, Budapest (Hungary)

5 More presentations in this session

Presentation thumbnail
Digoxin initiation in advanced heart failure with reduced ejection fraction and atrial fibrillation: a nationwide target trial emulation study
Doctor C. Basile (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Applicability of mineralocorticoid receptor antagonist trials to real-world patients with heart failure across the ejection fraction spectrum
Doctor B. Beer (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Impact of a pre-discharge checklist on temporal trends in gdmt prescription and clinical events in patients with heart failure
Assistant Professor J. Jang (Incheon, KR)
Abstract Slides Video
Presentation thumbnail
Temporal trends and determinants of heart failure therapy after myocardial infarction: a PROFID subanalysis
Doctor A. Sepehri Shamloo (Berlin, DE)
Abstract Slides Video
Presentation thumbnail
The prognostic role of a structured patient education programme among patients hospitalised for heart failure with reduced ejection fraction: To know or not to know, that is the question
Doctor F. Banfi-Bacsardi (Budapest, HU)
Abstract Slides Video

Access the full session

Session thumbnail
Diagnostic and prognostic biomarkers in heart failure (2)

The Event

Event poster

ESC Congress 2026

30 August 2026 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Influence of adherence and optimal pharmacological treatment on survival rates of hospitalized patients with decompensated heart failure
21 May 2023
thumbnail
Congress Session
Practical guidance to implement heart failure treatment with SGLT2 inhibitors in the outpatient setting
27 August 2023
thumbnail
Congress Presentation
A novel, Pillar-GDMT score for prediction of all-cause mortality in patients with heart failure with reduced ejection fraction requiring heart failure hospitalisation
1 September 2025
thumbnail
Congress Presentation
Tracking patient reported outcome measurements in heart failure: a five-year longitudinal digital implementation evaluation
14 June 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources